Search
Synairgen is a respiratory drug development company with a particular focus on lung antiviral defence in asthma, COPD and severe viral infections
Share price
Click above to open the London Stock Exchange website for the latest share price information More
Latest report & accounts
Copies of our Report and Accounts can be found here More
About us
Find out more about Synairgen, its Directors and Founders More
Latest News
Results of Annual General Meeting 10 June 2013 | More
Holding in Company 21 May 2013 | More
Notice of 2013 AGM 09 May 2013 | More
Posting of annual report and accounts 09 April 2013 | More
Grant of options 12 March 2013 | More
Preliminary results for the year ended 31 December 2012 13 February 2013 | More
Synairgen plc
Registered in England and Wales No. 5233429
Registered office
Mailpoint 810, Level F, South Block,Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK
